Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease

With continued high rates of adult obesity and DM along with an aging population, NAFLD-related liver disease and mortality will increase in the United States. Strategies to slow the growth of NAFLD cases and therapeutic options are necessary to mitigate disease burden. (Hepatology 2018;67:123-133).